RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort

Key Takeaways Resmed's Smart Comfort gets FDA clearance, offering AI-personalized CPAP settings for OSA patients.Resmed leverages AI and real-world sleep data to improve comfort and adherence in CPAP therapy.Resmed's Smart Comfort supports clinicians by easing setup, follow-up, and therapy management.Resmed (RMD) has received FDA clearance for Personalized Therapy Comfort Settings (“PTCS”), which will be marketed as Smart Comfort. The company will debut Smart Comfort in early 2026 in a limited U.S. beta ver ...